| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 8e-17 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-12 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |